- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 333/04 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulfur atom
Patent holdings for IPC class C07D 333/04
Total number of patents in this class: 66
10-year publication summary
|
1
|
1
|
0
|
2
|
5
|
5
|
4
|
3
|
5
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Sumitomo Chemical Company, Limited | 9046 |
4 |
| Akaal Pharma Pty Ltd. | 11 |
4 |
| AAT Bioquest, Inc. | 38 |
3 |
| Aldeyra Therapeutics, Inc. | 109 |
3 |
| Ottawa Hospital Research Institute | 109 |
3 |
| Allergan, Inc. | 2349 |
2 |
| Chinese PLA General Hospital | 41 |
2 |
| Fermenta Biotech Limited | 46 |
2 |
| Nocion Therapeutics, Inc. | 42 |
2 |
| Enyo Pharma | 57 |
2 |
| Novartis AG | 10849 |
1 |
| F. Hoffmann-La Roche AG | 7925 |
1 |
| BASF SE | 20933 |
1 |
| Merck & Co., Inc. | 331 |
1 |
| Pfizer Inc. | 3387 |
1 |
| Syngenta Limited | 456 |
1 |
| Abbott Laboratories | 2399 |
1 |
| Bayer Cropscience AG | 2035 |
1 |
| University of Southern California | 2112 |
1 |
| University of Florida Research Foundation, Inc. | 4020 |
1 |
| Other owners | 29 |